As another anti-cancer agent, dihydrotanshinone I can increase Nr2 degradation by Keap1 and it impairs Nr2 phosphorylation by PKC to reduce proliferation of gallbladder tumor (135). This evidence concerns the gene KEAP1 and cancer.